Acral Melanoma — Trials

Acral Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

29 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05789043	Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma	recruiting	Phase 3	140	Peking University Cancer Hospital & InstituteOTHER	1	Sep 6, 2023	clinicaltrials

Data updated 22 days agoSource updated Sep 6, 2023source: clinicaltrials